{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T16:00:41Z","timestamp":1790870441086,"version":"4.1.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T00:00:00Z","timestamp":1760918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T00:00:00Z","timestamp":1760918400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-64902-0","type":"journal-article","created":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T14:26:25Z","timestamp":1760970385000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Apolipoprotein A-IV fibrils: structural diagnosis of mixed cardiac amyloidosis"],"prefix":"10.1038","volume":"16","author":[{"given":"Shintaro","family":"Aibara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Astrid","family":"Kassner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edmond","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Klingel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Papworth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magnus","family":"Althage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9570-4411","authenticated-orcid":false,"given":"Qing-Dong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Correia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hendrik","family":"Milting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3231-8112","authenticated-orcid":false,"given":"Taiana Maia","family":"de Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,20]]},"reference":[{"key":"64902_CR1","doi-asserted-by":"crossref","unstructured":"Picken, M. M., Herrera, G. A. & Dogan, A. Amyloid and Related Disorders: Surgical Pathology and Clinical Correlations (Humana Press, 2015).","DOI":"10.1007\/978-3-319-19294-9"},{"key":"64902_CR2","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1146\/annurev-biochem-090908-120656","volume":"80","author":"BH Toyama","year":"2011","unstructured":"Toyama, B. H. & Weissman, J. S. Amyloid structure: conformational diversity and consequences. Annu. Rev. Biochem. 80, 557\u2013585 (2011).","journal-title":"Annu. Rev. Biochem."},{"key":"64902_CR3","doi-asserted-by":"publisher","first-page":"E125","DOI":"10.1093\/eurheartj\/suaa077","volume":"22","author":"CC Quarta","year":"2020","unstructured":"Quarta, C. C. et al. A new therapy for transthyretin amyloidosis, no longer an orphan condition. Eur. Heart J. Suppl. 22, E125\u2013E131 (2020).","journal-title":"Eur. Heart J. Suppl."},{"key":"64902_CR4","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/s41586-023-06437-2","volume":"621","author":"SHW Scheres","year":"2023","unstructured":"Scheres, S. H. W., Ryskeldi-Falcon, B. & Goedert, M. Molecular pathology of neurodegenerative diseases by cryo-EM of amyloids. Nature 621, 701\u2013710 (2023).","journal-title":"Nature"},{"key":"64902_CR5","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1007\/s12471-019-1299-1","volume":"27","author":"MIFJ Oerlemans","year":"2019","unstructured":"Oerlemans, M. I. F. J. et al. Cardiac amyloidosis: the need for early diagnosis. Neth. Heart J. 27, 525\u2013536 (2019).","journal-title":"Neth. Heart J."},{"key":"64902_CR6","first-page":"215","volume":"25","author":"MD Benson","year":"2018","unstructured":"Benson, M. D. et al. Amyloid nomenclature 2018: recommendations by the International Society of Amyloidosis (ISA) nomenclature committee. Amyloid Int. J. Exp. Clin. Investig. J. Int. Soc. Amyloidosis 25, 215\u2013219 (2018).","journal-title":"Amyloid Int. J. Exp. Clin. Investig. J. Int. Soc. Amyloidosis"},{"key":"64902_CR7","unstructured":"Papingiotis, G., Basmpana, L. & Farmakis, D. Cardiac amyloidosis: epidemiology, diagnosis and therapy. https:\/\/www.escardio.org\/Journals\/E-Journal-of-Cardiology-Practice\/Volume-19\/cardiac-amyloidosis-epidemiology-diagnosis-and-therapy."},{"key":"64902_CR8","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.3390\/jcm12062273","volume":"12","author":"R Ruiz-Hueso","year":"2023","unstructured":"Ruiz-Hueso, R. et al. Estimating the prevalence of cardiac amyloidosis in old patients with heart failure-barriers and opportunities for improvement: the PREVAMIC study. J. Clin. Med. 12, 2273 (2023).","journal-title":"J. Clin. Med."},{"key":"64902_CR9","doi-asserted-by":"publisher","first-page":"319","DOI":"10.3390\/cells8040319","volume":"8","author":"J Qu","year":"2019","unstructured":"Qu, J., Ko, C.-W., Tso, P. & Bhargava, A. Apolipoprotein A-IV: a multifunctional protein involved in protection against atherosclerosis and diabetes. Cells 8, 319 (2019).","journal-title":"Cells"},{"key":"64902_CR10","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1038\/labinvest.3700124","volume":"84","author":"J Bergstr\u00f6m","year":"2004","unstructured":"Bergstr\u00f6m, J. et al. Two different types of amyloid deposits\u2014apolipoprotein A-IV and transthyretin\u2014in a patient with systemic amyloidosis. Lab. Invest. 84, 981\u2013988 (2004).","journal-title":"Lab. Invest."},{"key":"64902_CR11","first-page":"001237","volume":"6","author":"E Martins","year":"2019","unstructured":"Martins, E. et al. Cardiac amyloidosis associated with apolipoprotein A-IV deposition diagnosed by mass spectrometry-based proteomic analysis. Eur. J. Case Rep. Intern. Med. 6, 001237 (2019).","journal-title":"Eur. J. Case Rep. Intern. Med."},{"key":"64902_CR12","first-page":"767","volume":"20","author":"X Deng","year":"2012","unstructured":"Deng, X. et al. The structure of dimeric apolipoprotein A-IV and its mechanism of self-association. Struct. Lond. Engl. 20, 767\u2013779 (2012).","journal-title":"Struct. Lond. Engl."},{"key":"64902_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13038-z","volume":"10","author":"M Schmidt","year":"2019","unstructured":"Schmidt, M. et al. Cryo-EM structure of a transthyretin-derived amyloid fibril from a patient with hereditary ATTR amyloidosis. Nat. Commun. 10, 5008 (2019).","journal-title":"Nat. Commun."},{"key":"64902_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-44820-3","volume":"15","author":"BA Nguyen","year":"2024","unstructured":"Nguyen, B. A. et al. Structural polymorphism of amyloid fibrils in ATTR amyloidosis revealed by cryo-electron microscopy. Nat. Commun. 15, 581 (2024).","journal-title":"Nat. Commun."},{"key":"64902_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-34552-7","volume":"13","author":"B Frieg","year":"2022","unstructured":"Frieg, B. et al. The 3D structure of lipidic fibrils of \u03b1-synuclein. Nat. Commun. 13, 6810 (2022).","journal-title":"Nat. Commun."},{"key":"64902_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-33591-4","volume":"13","author":"M Steinebrei","year":"2022","unstructured":"Steinebrei, M. et al. Cryo-EM structure of an ATTRwt amyloid fibril from systemic non-hereditary transthyretin amyloidosis. Nat. Commun. 13, 6398 (2022).","journal-title":"Nat. Commun."},{"key":"64902_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-27481-4","volume":"12","author":"I Iakovleva","year":"2021","unstructured":"Iakovleva, I. et al. Structural basis for transthyretin amyloid formation in vitreous body of the eye. Nat. Commun. 12, 7141 (2021).","journal-title":"Nat. Commun."},{"key":"64902_CR18","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1006\/bbrc.2001.5260","volume":"285","author":"J Bergstr\u00f6m","year":"2001","unstructured":"Bergstr\u00f6m, J. et al. Codeposition of apolipoprotein A-IV and transthyretin in senile systemic (ATTR) amyloidosis. Biochem. Biophys. Res. Commun. 285, 903\u2013908 (2001).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"64902_CR19","doi-asserted-by":"publisher","first-page":"168441","DOI":"10.1016\/j.jmb.2024.168441","volume":"436","author":"G Andreotti","year":"2024","unstructured":"Andreotti, G. et al. Insights into the structural basis of amyloid resistance provided by cryo-EM structures of AApoAII amyloid fibrils. J. Mol. Biol. 436, 168441 (2024).","journal-title":"J. Mol. Biol."},{"key":"64902_CR20","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/978-3-319-17344-3_8","volume":"855","author":"M Das","year":"2015","unstructured":"Das, M. & Gursky, O. Amyloid-forming properties of human apolipoproteins: sequence analyses and structural insights. Adv. Exp. Med. Biol. 855, 175\u2013211 (2015).","journal-title":"Adv. Exp. Med. Biol."},{"key":"64902_CR21","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/s41586-023-06788-w","volume":"625","author":"S L\u00f6vestam","year":"2024","unstructured":"L\u00f6vestam, S. et al. Disease-specific tau filaments assemble via polymorphic intermediates. Nature 625, 119\u2013125 (2024).","journal-title":"Nature"},{"key":"64902_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-05971-2","volume":"9","author":"B Li","year":"2018","unstructured":"Li, B. et al. Cryo-EM of full-length \u03b1-synuclein reveals fibril polymorphs with a common structural kernel. Nat. Commun. 9, 3609 (2018).","journal-title":"Nat. Commun."},{"key":"64902_CR23","doi-asserted-by":"publisher","first-page":"4822","DOI":"10.1002\/anie.201511524","volume":"55","author":"K Annamalai","year":"2016","unstructured":"Annamalai, K. et al. Polymorphism of amyloid fibrils in vivo. Angew. Chem. Int. Ed. Engl. 55, 4822\u20134825 (2016).","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"64902_CR24","doi-asserted-by":"publisher","first-page":"3551","DOI":"10.1002\/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2","volume":"20","author":"DN Perkins","year":"1999","unstructured":"Perkins, D. N., Pappin, D. J., Creasy, D. M. & Cottrell, J. S. Probability-based protein identification by searching sequence databases using mass spectrometry data. Electrophoresis 20, 3551\u20133567 (1999).","journal-title":"Electrophoresis"},{"key":"64902_CR25","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1107\/S2059798319016577","volume":"76","author":"SHW Scheres","year":"2020","unstructured":"Scheres, S. H. W. Amyloid structure determination in RELION-3.1. Acta Crystallogr. Sect. Struct. Biol. 76, 94\u2013101 (2020).","journal-title":"Acta Crystallogr. Sect. Struct. Biol."},{"key":"64902_CR26","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.jsb.2012.09.006","volume":"180","author":"SHW Scheres","year":"2012","unstructured":"Scheres, S. H. W. RELION: implementation of a Bayesian approach to cryo-EM structure determination. J. Struct. Biol. 180, 519\u2013530 (2012).","journal-title":"J. Struct. Biol."},{"key":"64902_CR27","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1039\/D2FD00034B","volume":"240","author":"S L\u00f6vestam","year":"2022","unstructured":"L\u00f6vestam, S. & Scheres, S. H. W. High-throughput cryo-EM structure determination of amyloids. Faraday Discuss 240, 243\u2013260 (2022).","journal-title":"Faraday Discuss"},{"key":"64902_CR28","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1038\/s41586-024-07215-4","volume":"628","author":"K Jamali","year":"2024","unstructured":"Jamali, K. et al. Automated model building and protein identification in cryo-EM maps. Nature 628, 450\u2013457 (2024).","journal-title":"Nature"},{"key":"64902_CR29","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1002\/pro.3791","volume":"29","author":"A Casa\u00f1al","year":"2020","unstructured":"Casa\u00f1al, A., Lohkamp, B. & Emsley, P. Current developments in Coot for macromolecular model building of Electron Cryo-microscopy and Crystallographic Data. Protein Sci. Publ. Protein Soc. 29, 1069\u20131078 (2020).","journal-title":"Protein Sci. Publ. Protein Soc."},{"key":"64902_CR30","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1107\/S2059798321009475","volume":"77","author":"K Yamashita","year":"2021","unstructured":"Yamashita, K., Palmer, C. M., Burnley, T. & Murshudov, G. N. Cryo-EM single-particle structure refinement and map calculation using Servalcat. Acta Crystallogr. Sect. Struct. Biol. 77, 1282\u20131291 (2021).","journal-title":"Acta Crystallogr. Sect. Struct. Biol."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-64902-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-64902-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-64902-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T14:26:26Z","timestamp":1760970386000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-64902-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,20]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["64902"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-64902-0","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,20]]},"assertion":[{"value":"4 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"S.A., E.W., M.P., M.A., Q.D.W., C.C., and T.M.O. are current employees of AstraZeneca and have stock ownership and\/or stock options or interests in the company. A.K., K.K., and H.M. declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9276"}}